Prophylactic intravenous immunoglobulin reduces COVID-19 infection rates in older patients with DLBCL with hypogammaglobulinemia undergoing reduced-intensity R-CHOP therapy. The study, conducted ...
"I realized there were a lot of other people across the country doing the same thing I was. So I figured I could connect with ...
Please provide your email address to receive an email when new articles are posted on . IVIG had favorable effects on skin thickening, muscle and joint pain, and gastrointestinal symptoms of systemic ...
Kelley L. Julian, PharmD, BCOP, discusses optimizing myeloma care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute.
"[O]ur study, which has the largest cohort to date, did not show an increased rate of VTEs in patients with DM on IVIG. Therefore, it is safe to start patients on this medicine as it is one of our ...
Credit: Getty Images. GC5107B is a liquid solution containing 10% immunoglobulin G for IV infusion, manufactured from pooled human plasma from US donors. The Food and Drug Administration (FDA) has ...
GC Biopharma USA, Inc., a leader in plasma-derived products, announced today that it will host a sponsored symposium and present two scientific posters at the 2025 Immunoglobulin National Society ...
Kedrion Biopharma is proud to announce the U.S. availability of YIMMUGO (Immune Globulin Intravenous, Human-dira, 10%), ...
Neurologist Susan W. Lee, DO, answers common questions about this treatment option for myasthenia gravis. Intravenous immunoglobulin (IVIG) is a pooled collection of antibodies derived from donors’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results